Skip to main content

Table 4 Self-reported complaints post day 1 of treatment ‘adverse events’

From: Optimal timing of primaquine to reduce Plasmodium falciparum gametocyte carriage when co-administered with artemether–lumefantrine

Adverse effectsAL onlyAL + primaquine day 1AL + primaquine day 3
Participants with adverse events (%)9 (34.6)6 (23.1)11 (42.3)
Number of adverse events*10813
Cough432
Skin rush100
Headache214
Dizziness100
Abdominal discomfort/pain221
Loss of appetite012
Vomiting001
Diarrhoea001
Otitis media010
Conjunctivitis001
Painful micturition001
  1. AL artemether–lumefantrine
  2. *44% of adverse events were reported on day 2 of follow up